Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Lobo de Figueiredo

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Revista Da Associacao Medica Brasileira (1992)|April 9, 2008
[From the molecular model to the impact on prognosis: an overview on acute promyelocytic leukemia]Rafael Henriques Jácomo, Lorena Lobo de Figueiredo-Pontes, Eduardo Magalhães Rego
Mediators of Inflammation|June 30, 2004
Granulocyte colony-stimulating factor and leukemogenesisLorena Lobo de Figueiredo, Rodrigo Siqueira de Abreu e Lima, Eduardo Magalhães Rego
Medical Oncology (Northwood, London, England)|April 30, 2011
Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemiaFábio Morato de Oliveira, Lorena Lobo de Figueiredo Pontes, Sarah Cristina Bassi, et al.
Hematology, Transfusion and Cell Therapy|May 8, 2024
Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemiaSitânia Chiesa, Eduardo Magalhães Rego, Vanessa Teich, et al.
Medical Oncology (Northwood, London, England)|March 8, 2011
Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemiaAntonio Roberto Lucena-Araujo, Lorena Lobo de Figueiredo-Pontes, Fábio Morato de Oliveira, et al.
Hematology, Transfusion and Cell Therapy|November 3, 2019
Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasmsMoysés Antonio Porto-Soares, Rafael Daltro de Oliveira, Gabriel Macedo Cortopassi, et al.
Cancer Cell|May 13, 2015
Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cellsRobert S Welner, Giovanni Amabile, Deepak Bararia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
Identification and characterization of ALK kinase splicing isoforms in non-small-cell lung cancerLorena Lobo de Figueiredo-Pontes, Daisy Wing-Sze Wong, Vicky Pui-Chi Tin, et al.
Hematology, Transfusion and Cell Therapy|November 29, 2025
Mesenchymal stromal cells secretory pattern contributes to oncoinflammatory bone marrow microenvironment in polycythemia veraJuçara Gastaldi Cominal, Maira da Costa Cacemiro, Giovana Michelassi Berbel, et al.
Frontiers in Oncology|May 23, 2024
Kinetics of <i>BCR::ABL1</i> transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML studyBruna Murbach, Gislaine Duarte, Leonardo Carvalho Palma, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Revista Da Associacao Medica Brasileira (1992)|April 9, 2008
[From the molecular model to the impact on prognosis: an overview on acute promyelocytic leukemia]Rafael Henriques Jácomo, Lorena Lobo de Figueiredo-Pontes, Eduardo Magalhães Rego
Mediators of Inflammation|June 30, 2004
Granulocyte colony-stimulating factor and leukemogenesisLorena Lobo de Figueiredo, Rodrigo Siqueira de Abreu e Lima, Eduardo Magalhães Rego
Medical Oncology (Northwood, London, England)|April 30, 2011
Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemiaFábio Morato de Oliveira, Lorena Lobo de Figueiredo Pontes, Sarah Cristina Bassi, et al.
Hematology, Transfusion and Cell Therapy|May 8, 2024
Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemiaSitânia Chiesa, Eduardo Magalhães Rego, Vanessa Teich, et al.
Medical Oncology (Northwood, London, England)|March 8, 2011
Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemiaAntonio Roberto Lucena-Araujo, Lorena Lobo de Figueiredo-Pontes, Fábio Morato de Oliveira, et al.
Hematology, Transfusion and Cell Therapy|November 3, 2019
Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasmsMoysés Antonio Porto-Soares, Rafael Daltro de Oliveira, Gabriel Macedo Cortopassi, et al.
Cancer Cell|May 13, 2015
Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cellsRobert S Welner, Giovanni Amabile, Deepak Bararia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
Identification and characterization of ALK kinase splicing isoforms in non-small-cell lung cancerLorena Lobo de Figueiredo-Pontes, Daisy Wing-Sze Wong, Vicky Pui-Chi Tin, et al.
Hematology, Transfusion and Cell Therapy|November 29, 2025
Mesenchymal stromal cells secretory pattern contributes to oncoinflammatory bone marrow microenvironment in polycythemia veraJuçara Gastaldi Cominal, Maira da Costa Cacemiro, Giovana Michelassi Berbel, et al.
Frontiers in Oncology|May 23, 2024
Kinetics of <i>BCR::ABL1</i> transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML studyBruna Murbach, Gislaine Duarte, Leonardo Carvalho Palma, et al.
Pageof 3